034sek
3,9 %
Date:2024-03-28Time:12:59:00Latest report:Q3-2023List:First NorthTicker:KLAR
Market Cap:37 msekEnterprise Value:34 msekNet Sales:13,0 msekEarnings:-39,2 msekEmployees:0ISIN:SE0007280326

Ratios

10-year key figure history for Klaria Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Klaria Pharma with index and moving average MA50 and MA200.

Stockprice:0,34
MA50:0,44
MA200:0,51
Price/MA200:-32,7 %
RSI (14):48,6
Price/MA50:-21,5 %

Description

Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group’s operations are conducted in Sweden.

Biotechnology